Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Nadine, Kutsch"'
Autor:
Nadine Kutsch, Sandra Robrecht, Anna Fink, Elisabeth Lange, Rudolf Weide, Michael G. Kiehl, Martin Sökler, Rudolf Schlag, Ursula Vehling‐Kaiser, Georg Köchling, Christoph Plöger, Michael Gregor, Torben Plesner, Michael R. Clausen, Ilske Oschlies, Matthias Ritgen, Marco Herling, Kirsten Fischer, Hartmut Döhner, Clemens‐Martin Wendtner, Karl‐Anton Kreuzer, Stephan Stilgenbauer, Michael Hallek, Sebastian Böttcher, Wolfram Klapper, Barbara Eichhorst
Publikováno v:
HemaSphere, Vol 8, Iss 7, Pp n/a-n/a (2024)
Externí odkaz:
https://doaj.org/article/44d232eb23a94fed9624ca9d7e5fa99f
Autor:
Jan-Michel Heger, Julia Mattlener, Philipp Gödel, Hyatt Balke-Want, Noëlle Sieg, Nadine Kutsch, Richard Lewis, Fabian Ullrich, Roland F. Schwarz, Kerstin Becker, Jonathan Weiss, H. Christian Reinhardt, Michael Hallek, Peter Borchmann, Bastian von Tresckow, Sven Borchmann
Publikováno v:
HemaSphere, Vol 7, p e45690bd (2023)
Externí odkaz:
https://doaj.org/article/4da024e7441c4c5c9cdc01e980255a86
Autor:
Conrad-Amadeus Voltin, Philipp Gödel, Laura Beckmann, Jan-Michel Heger, Carsten Kobe, Nadine Kutsch, Peter Borchmann, Markus Dietlein, Ken Herrmann, Matthias Stelljes, Kambiz Rahbar, Georg Lenz, H. Christian Reinhardt, Marcel Teichert, Richard Noppeney, Jörn C. Albring, Robert Seifert, Bastian von Tresckow, Sarah Flossdorf, Christine Hanoun
Publikováno v:
HemaSphere, Vol 7, Iss 1, p e817 (2023)
The introduction of chimeric antigen receptor (CAR) T-cell therapy has led to a fundamental shift in the management of relapsed and refractory large B-cell lymphoma. However, our understanding of risk factors associated with non-response is still ins
Externí odkaz:
https://doaj.org/article/00e11d7dcadb4ef1933acac43af2c1ef
Autor:
Nadine Kutsch, Philipp Gödel, Conrad-Amadeus Voltin, Carsten Kobe, Michael Hallek, Christof Scheid, Peter Borchmann, Udo Holtick
Publikováno v:
HemaSphere, Vol 6, Iss 7, p e735 (2022)
Externí odkaz:
https://doaj.org/article/d4619a9b415345a2aa6cfcb57f57efe7
Autor:
Nadine Kutsch, Christian Pallasch, Thomas Decker, Holger Hebart, Kai Uwe Chow, Ullrich Graeven, Jens Kisro, Alexander Kroeber, Eugen Tausch, Kirsten Fischer, Anna-Maria Fink, Clemens-Martin Wendtner, Matthias Ritgen, Stephan Stilgenbauer, Danjie Zhang, Biao Li, Juliane M. Jürgensmeier, Nishanthan Rajakumaraswamy, Pankaj Bhargava, Michael Hallek, Barbara Eichhorst
Publikováno v:
HemaSphere, Vol 6, Iss 6, p e729 (2022)
Externí odkaz:
https://doaj.org/article/dcb0aae89c3a4826bbe95658972ef6d0
Autor:
Nadine Kutsch, Christian Pallasch, Eugen Tausch, Volkmar Böhme, Matthias Ritgen, Rüdiger Liersch, Alexander Wacker, Georg Jacobs, Ralf Ulrich Trappe, Peter Dreger, Kirsten Fischer, Anna-Maria Fink, Stephan Stilgenbauer, Shuyan Zhai, Biao Li, Juliane M. Jürgensmeier, Nishanthan Rajakumaraswamy, Pankaj Bhargava, Michael Hallek, Barbara F. Eichhorst
Publikováno v:
HemaSphere, Vol 6, Iss 4, p e692 (2022)
Externí odkaz:
https://doaj.org/article/cc1dd22b903a4e9bb9d8ee19e48800b6
Autor:
Philipp Gödel, Noëlle Sieg, Jan-Michel Heger, Nadine Kutsch, Carmen Herling, Ben-Niklas Bärmann, Christof Scheid, Peter Borchmann, Udo Holtick
Publikováno v:
HemaSphere, Vol 5, Iss 3, p e545 (2021)
Externí odkaz:
https://doaj.org/article/4d3daf41330d45e99745c6a00998110d
Autor:
Nadine Kutsch, Jasmin Bahlo, Sandra Robrecht, Jeremy Franklin, Can Zhang, Christian Maurer, Nisha De Silva, Elisabeth Lange, Rudolf Weide, Michael G. Kiehl, Martin Sökler, Rudolf Schlag, Ursula Vehling-Kaiser, Georg Köchling, Christoph Plöger, Michael Gregor, Torben Plesner, Marco Herling, Kirsten Fischer, Hartmut Döhner, Michael Kneba, Clemens-Martin Wendtner, Wolfram Klapper, Karl-Anton Kreuzer, Sebastian Böttcher, Stephan Stilgenbauer, Anna Maria Fink, Michael Hallek, Barbara Eichhorst
Publikováno v:
HemaSphere, Vol 4, Iss 1, p e336 (2020)
Abstract. Fludarabine, cyclophosphamide and rituximab (FCR) was compared to bendamustine and rituximab (BR) in an international, randomized, open label, phase 3 trial in 561 previously untreated, fit patients with chronic lymphocytic leukemia (CLL) w
Externí odkaz:
https://doaj.org/article/9ab624e05ae342d4ae618cb2980e0b9d
Autor:
Carmen D. Herling, Nima Abedpour, Jonathan Weiss, Anna Schmitt, Ron Daniel Jachimowicz, Olaf Merkel, Maria Cartolano, Sebastian Oberbeck, Petra Mayer, Valeska Berg, Daniel Thomalla, Nadine Kutsch, Marius Stiefelhagen, Paula Cramer, Clemens-Martin Wendtner, Thorsten Persigehl, Andreas Saleh, Janine Altmüller, Peter Nürnberg, Christian Pallasch, Viktor Achter, Ulrich Lang, Barbara Eichhorst, Roberta Castiglione, Stephan C. Schäfer, Reinhard Büttner, Karl-Anton Kreuzer, Hans Christian Reinhardt, Michael Hallek, Lukas P. Frenzel, Martin Peifer
Publikováno v:
Nature Communications, Vol 9, Iss 1, Pp 1-8 (2018)
BCL2-inhibitor venetoclax is used to treat relapsed/refractory chronic lymphocytic leukemia (CLL). Here, the authors show the clonal dynamics towards venetoclax resistance by performing whole-exome sequencing of 8 CLL patients undergoing venetoclax t
Externí odkaz:
https://doaj.org/article/91cad87502c5439c87643a607b72a378
Autor:
Nadine, Kutsch, Emily Eva, Holmes, Sandra, Robrecht, Gudrun, Schüler, Ursula, Vehling-Kaiser, Thomas, Decker, Sigrun, Müller-Hagen, Karin, Heinisch, Sebastian, Böttcher, Matthias, Ritgen, Karl-Anton, Kreuzer, Stephan, Stilgenbauer, Anna Maria, Fink, Kirsten, Fischer, Barbara, Eichhorst, Michael, Hallek, Clemens-Martin, Wendtner
Publikováno v:
Leukemia & Lymphoma. 64:478-482
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c97dfe081d644c3f0704f17856808bb
https://doi.org/10.1080/10428194.2022.2148210
https://doi.org/10.1080/10428194.2022.2148210